Systemic Therapy in Men with Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline
Version:
2
ID:
3-15
Sep 2014
Type of Content: Guidelines & Advice, Clinical
Document Status: In-Review
Guideline Objective
To provide treatment recommendations for men with metastatic castration-resistant prostate cancer (CRPC).
Patient Population
Men with metastatic castration-resistant prostate cancer.
Research Question(s)
In men with metastatic castration-resistant prostate cancer (mCRPC), which systemic therapies improve cancer- or patient-related outcomes?
![application/pdf pdf download](/sites/ccocancercare/themes/CCOp2/images/icons/application-pdf.png)
![application/pdf pdf download](/sites/ccocancercare/themes/CCOp2/images/icons/application-pdf.png)